Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lorcaserin Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110156608B reveals a novel catalytic route for p-chlorophenethylamine, offering safer processing and high purity for reliable pharmaceutical intermediate suppliers.
Advanced synthesis route for Lorcaserin intermediate offering cost reduction and scalability for pharmaceutical manufacturing supply chains globally.
Patent CN106631823B details a safe, cost-effective synthesis of lorcaserin intermediates using sodium borohydride reduction, eliminating toxic borane and expensive reagents.
Novel one-step synthesis for Lorcaserin intermediate. High purity, cost-effective, scalable production for global pharmaceutical supply chains and procurement.